Oakbrook Investments’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-26,350
Closed -$466K 598
2019
Q3
$466K Buy
26,350
+8,700
+49% +$176K 0.03% 398
2019
Q2
$377K Sell
17,650
-18,950
-52% -$397K 0.02% 447
2019
Q1
$871K Buy
36,600
+500
+1% +$11.4K 0.05% 276
2018
Q4
$710K Buy
36,100
+24,600
+214% +$439K 0.05% 293
2018
Q3
$204K Sell
11,500
-18,950
-62% -$370K 0.01% 621
2018
Q2
$655K Buy
+30,450
New +$630K 0.04% 295

Other funds holding EXEL

Oakbrook Investments's EXEL Position: Q4 2019 in Review

Oakbrook Investments sold out of Exelixis (EXEL) in Q4 2019, closing a stake of 26,350 shares — an estimated $466K sold.

Oakbrook Investments first reported a position in EXEL in Q2 2018 and held it in 6 quarters. The position peaked at $871K in Q1 2019. 328 funds tracked by Wall St. Rank hold EXEL as of Q4 2019.

  • Oakbrook Investments reported no remaining Exelixis position as of Q4 2019 after selling out during the quarter.
  • Oakbrook Investments sold 26,350 Exelixis shares in Q4 2019, an estimated $466K.
  • Oakbrook Investments first reported a position in Exelixis in Q2 2018 and held it in 6 quarters.
  • Oakbrook Investments's Exelixis position peaked at $871K in Q1 2019.
  • 328 funds tracked by Wall St. Rank held Exelixis as of Q4 2019.

Based on Oakbrook Investments's 13F filing for Q4 2019, filed 6 Feb 2020.